poor prospects, page-2

building that production plant was their demise.
un like cmq Imugene imu have gone for sub contract manufacture and partnering deals with global pharmas.
biotec start ups are a money hungry area.
to be successful you need to get in with the bigs of the industry like merial intervet etc because they have the resources,knowhow and might/
imu will be the success story which could have been cmq had they chose a different path.